FDA approves JUUL vapes
Digest more
1h
MiBolsilloColombia on MSNUrgent Health Alert: FDA Recalls Over 110,000 Ice Cream Boxes Due to Listeria RiskThe FDA has issued a Class II recall for over 110,000 ice cream boxes potentially contaminated with Listeria monocytogenes. This recall, initiated by Rich Ice Cream Co., highlights the serious health risks posed by this bacteria,
Drugmaker Sarepta Therapeutics said it won’t comply with a request from the FDA to halt all shipments of its gene therapy following the death of a third patient receiving one of its
Calangute: The Food and Drugs Administration (FDA) has clarified that the spoiled chicken meat which had been seized at Arpora was disposed of as stipulated by official guidelines.“Regarding the disposal of the chicken meat,
The U.S. Food and Drug Administration approved a new blue color additive derived from the fruit of the gardenia, a flowering evergreen, for use in a variety of drinks and candies.
WASHINGTON — The US Food and Drug Administration aims to revoke 52 standards of identity (SOI) across a swath of food categories, claiming the regulations are “obsolete and unnecessary.”
Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) combinations. The belantamab mafodotin combinations were evaluated in adults with relapsed or refractory multiple myeloma who have received at least one prior line of therapy.
3d
EatingWell on MSNThe FDA Just Approved a New Food Dye, but What Makes It Different?The FDA just approved Gardenia (genipin) blue, a natural food dye, for certain foods and drinks. They’re also trying to expedite the ban of Red No. 3 before the January 15, 2027, deadline. Some grocers have already pledged not to sell foods with petroleum-based synthetic food dyes.
The 5th Circuit ruled on Aug. 16 that it would limit access to mifepristone, finding that the Food and Drug Administration overstepped its authority with a series of actions that made it easier ...
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy.